Ranjani Raghavan
Healthcare
Chinese conglomerate eyes majority stake in DEG-backed Ivy Health
A Chinese conglomerate has thrown its hat in the ring to pick up a majority stake in Punjab-headquartered multispecialty chain ......
Finance
India Alternatives, IIFL pre-IPO fund back financial services company
Private equity firm India Alternatives Investment Advisors Ltd and IIFL Asset Management Pvt. Ltd have invested in a financial services ......
Healthcare
UAE-based investment firm may give Matrix exit from Centre For Sight
Eye-care chain Centre for Sight, which shelved its plans to go public last year, is now in talks with a ......
Healthcare
Temasek in talks to invest in eye-care chain
Singapore state investment firm Temasek Holdings is in advanced talks to invest in an eye-care chain as it looks to ......
Healthcare
Indian generic drugmakers must evolve: Cipla's Umang Vohra at VCCircle event
Indian pharmaceutical companies need to diversify beyond their generics business in order to sustain growth, Cipla Ltd CEO Umang Vohra ......
People
Will ramp up VC play; financial returns not sole focus: OPIC's David Bohigian
The US’ Overseas Private Investment Corporation (OPIC) is among a clutch of development finance institutions that have emerged as a ......
Finance
OPIC to add venture capital funds to its LP portfolio
The Overseas Private Investment Corporation (OPIC) has come in as a limited partner (LP) for venture capital firm Iron Pillar’s ......
Finance
Fund Scan: TPG puts pedal to the metal as it rewrites India playbook
In late 2010, a few years before stressed assets and private equity investors’ interest in debt-laden companies started making headlines, ......
Healthcare
Carlyle to pare stake in Metropolis Healthcare before IPO
Private equity firm Carlyle Group, which plans to divest a big chunk of its stake in Metropolis Healthcare Ltd through ......
Healthcare
CX Partners set to make maiden bet from new fund
CX Partners is close to investing in a clinical research company in what will mark the homegrown private equity firm’s ......
